We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
 

RELATED ARTICLES

"Missing" Virus Detected in Children With Polio-like Paralysis

News

Study is first to find clear signs of enterovirus in the nervous system of AFM patients, providing the strongest evidence to date that the disease is viral.

READ MORE

Immune Cells Rewire and Repair the Brain While We Sleep

News

A new study suggests that the brain's immune cells, which help to repair damage, are primarily active while we sleep.

READ MORE

British Columbia’s HPV Vaccination Program Reduces Cervical Pre-cancer Rates by > 50%

News

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE